Contribution of the renin-angiotensin-aldosterone system to development of tolerance and fluid retention in chronic congestive heart failure during prazosin treatment
- 1 April 1987
- journal article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 59 (8) , 906-910
- https://doi.org/10.1016/0002-9149(87)91117-9
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Plasma renin activity and plasma concentrations of norepinephrine and cyclic nucleotides in heart failure after prazosinClinical Pharmacology & Therapeutics, 1981
- Increase in plasma norepinephrine during prazosin therapy for chronic congestive heart failureThe American Journal of Medicine, 1981
- Increased Plasma Norepinephrine Levels During Prazosin Therapy for Severe Congestive Heart FailureAnnals of Internal Medicine, 1980
- Long-term therapy of heart failure with prazosin: A randomized double blind trialPublished by Elsevier ,1980
- Development of pharmacodynamic tolerance to prazosin in congestive heart failureThe American Journal of Cardiology, 1979
- Marked early attenuation of hemodynamic effects of oral prazosin therapy in chronic congestive heart failureThe American Journal of Cardiology, 1979
- Attenuation of Prazosin Effect on Cardiac Output in Chronic Heart FailureAnnals of Internal Medicine, 1979
- Hemodynamic and clinical tachyphylaxis to prazosin-mediated afterload reduction in severe chronic congestive heart failure.Circulation, 1979
- PrazosinNew England Journal of Medicine, 1979
- Clinical pharmacology and therapeutic application of prazosin in acute and chronic refractory congestive heart failureThe American Journal of Medicine, 1978